Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

WHO Consults On New Framework To Evaluate And List Regulatory Authorities

Executive Summary

The new framework, when finalized, will replace the widely-recognized concept of "stringent regulatory authorities." 

You may also be interested in...



First Three Medicine Regulators Gain ‘WHO-Listed Authority’ Status

WHO Forges Ahead With New Framework To List Regulatory Authorities

The World Health Organization is to consult on a policy document explaining how it intends to evaluate and list regulatory authorities that meet certain criteria. The new concept of “WHO-listed authority” will replace the current “stringent regulatory authority.”

Ambitious WHO Plan To Help 50 Nations Improve Regulatory Capacity

The World Health Organization has drawn up a plan to help member states build effective and efficient regulatory systems in order to deliver quality-assured medical products for all.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS125321

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel